Moaz A Kamel, Isabel G Scalia, Amro T Badr, Nima Baba Ali, Juan M Farina, Milagros Pereyra, Mohammed Tiseer Abbas, Ahmed K Mahmoud, Robert L Scott, David E Steidley, Julie L Rosenthal, Lisa M Lemond, Kristen A Sell-Dottin, Brian W Hardaway, Timothy Barry, Ming Yang, Chieh-Ju Chao, Clinton E Jokerst, Chadi Ayoub, Reza Arsanjani
Cardiac allograft vasculopathy (CAV) is a distinct form of coronary artery disease that represents a major cause of death beyond the first year after heart transplantation. The pathophysiology of CAV is still not completely elucidated; it involves progressive circumferential wall thickening of both the epicardial and intramyocardial coronary arteries. Coronary angiography is still considered the gold-standard test for the diagnosis of CAV, and intravascular ultrasound (IVUS) can detect early intimal thickening with improved sensitivity...
March 21, 2024: Journal of Cardiovascular Development and Disease